Champions Oncology Inc
Save
–
Market cap
–
Current P/E
22.32x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.
Similar securities
Based on sector and market capitalization
Report issue